A cost-benefit analysis of scaling up tuberculosis control in India.

editor score
Editor Score:
85
editor score
Quality:
89
editor score
Usability:
89
editor score
Reliability:
95
Asset Type
License
Free
Expiration
Wednesday, January 7, 2026
Geography
map
North America Central America South America Oceania Scandinavia Europe Africa Middle East Asia
Publication year
2011
Industry
Life science/Healthcare

The study carries out a systematic analysis to measure the economic costs and benefits of scaling up tuberculosis (TB) control under the Revised National Tuberculosis Control Programme (RNTCP) in India.

Yegii expert:
Author:
Goodchild, M., Sahu, S., Wares, F., Dewan, P., Shukla, R. S., Chauhan, L. S., & Floyd, K
Publisher:
The International Journal of Tuberculosis and Lung Disease, 15(3), 358-362.
Time horizon:
Decade(s)
Editor review:
This semi-academic article provides a good analysis on the measurement of economic costs and benefits of scaling up the RNTCP program in India. It provides the benefits in terms of DALYS and monetary number which is useful for both public health and finance policy researchers. It concludes that The scale-up of TB control has been a very cost-effective strategy for improving the health status of India’s population, while the return on investment has been exceptional from a societal perspective. An updated analysis for 2015 would be a welcome addition to this analysis.
Yegii Reviews: